Nous contacter / Prendre rendez-vous

1995-2000

  • Rengarajan, K, de Smet MD, Wiggert B: A simple method for efficient and rapid removal of albumin from multiple human serum samples. BioTechniques 20: 30-32. 1996.
  • de Smet MD, Stark-Vancs V, Kohler D, Smith J, Nussenblatt RB, Wittes R: Intraocular levels of methotrexate following intravenous administration. Am J Ophthalmol 121:442-444, 1996.
  • de Smet MD: Discussion of Low-Dose Cyclosporine A in the treatment of uveitis (A. Vitale et al). Ophthalmol 103: 373-374, 1996.
  • Nussenblatt RB, Whitcup SM, de Smet MD, Caspi RR, Kozhich AT, Weiner HL, Vistica B, Gery I: Intraocular inflammatory disease (uveitis) and the use of oral tolearnce: a status report. Ann NY Acad Sci 778:325-37, 1996.
  • Ramadan A, Nussenblatt RB, de Smet MD: Long Term Follow Up of Patients with Endogenous Uveitis Treated with Combination Cyclosporine and Ketoconazole. Ophthalmology. 104(4): 706-11, 1997.
  • Hikita N, Lopez JS, Chan CC, Mochizuki M, Nussenblatt RB, de Smet MD: Use of topical FK 506 in a corneal graft rejection model in the Lewis rat. Invest Ophthalmol Vis Sci 38: 901-909, 1997.
  • de Smet MD, Dayan M, Nussenblatt RB: A novel method for the determination of T-cell proliferative responses in patients with uveitis. Ocular Immunol Inflam 6: 173-178, 1998.
  • Meenken C, van den Horn G J, de Smet MD, van der Meer JTM: Optic neuritis heralding varicella zoster virus retinitis in a patient with AIDS. Ann Neurol 43: 534-536, 1998.
  • van den Horn GJ, Meenken C, Danner SA, Reiss P, de Smet MD: Effect of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients. Br J Ophthalmol 82: 988-990, 1998.
  • Roberge FG, de Smet, MD, Benichou J, Kriete M F, Raber J, Hakimi J: Treatment of uveitis with recombinant human interleukin 13. Br J Opthalmol 82: 1195-1198, 1998.
  • Sandor V, Stark-Vancs V, Pearson D, Nussenblatt R, Whitcup SM, Brouwer P, Patronas N, Heiss J, Jaffe E, de Smet M, Kohler D, Simon R, Wittes R: Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16: 3000-6, 1998.
  • de Smet MD, Stark-Vancs, V, Kohler D, Solomon D, Chan CC: Treatment of recurrent intraocular lymphoma with intravitreal chemotherapy. Br J Ophthalmol 83: 448-451, 1999.
  • Verbraak FD, Boom R, Wertheim-van Dillen PME, van den Horn GJ, Kijlstra A, de Smet MD: Influence of highly active anti-retroviral therapy (HAART) on the develoment of CMV disease in HIV positive patients at high risk for CMV disease. Br J Ophthalmol 83: 1186-1189, 1999.
  • de Smet MD, Meenken I, van den Horn GJ: Fomivirsen – an anti-CMV phosphorothioate oligonucleotide for the treatment of CMV retinitis. Ocular Immunol Infl 7:189-198, 1999.
  • Ongkosuwito, JV, Kortbeek LM, Van der Lelij A, Molicka, E, Kijlstra A, de Smet MD: Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands. Br J Ophthalmol 83: 535-539, 1999.